Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 2
2012 5
2013 5
2014 5
2015 6
2016 8
2017 5
2018 5
2019 3
2020 12
2021 10
2022 10
2023 14
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

84 results

Results by year

Filters applied: . Clear all
Page 1
Association between Initial Treatment Strategy and Long-Term Survival in Pulmonary Arterial Hypertension.
Boucly A, Savale L, Jaïs X, Bauer F, Bergot E, Bertoletti L, Beurnier A, Bourdin A, Bouvaist H, Bulifon S, Chabanne C, Chaouat A, Cottin V, Dauphin C, Degano B, De Groote P, Favrolt N, Feng Y, Horeau-Langlard D, Jevnikar M, Jutant EM, Liang Z, Magro P, Mauran P, Moceri P, Mornex JF, Palat S, Parent F, Picard F, Pichon J, Poubeau P, Prévot G, Renard S, Reynaud-Gaubert M, Riou M, Roblot P, Sanchez O, Seferian A, Tromeur C, Weatherald J, Simonneau G, Montani D, Humbert M, Sitbon O. Boucly A, et al. Among authors: seferian a. Am J Respir Crit Care Med. 2021 Oct 1;204(7):842-854. doi: 10.1164/rccm.202009-3698OC. Am J Respir Crit Care Med. 2021. PMID: 34185620 Free article.
Sarcoidosis-Associated Pulmonary Hypertension.
Savale L, Dorfmüller P, Boucly A, Jaïs X, Lacoste-Palasset T, Jevnikar M, Seferian A, Humbert M, Sitbon O, Montani D. Savale L, et al. Among authors: seferian a. Clin Chest Med. 2024 Mar;45(1):185-197. doi: 10.1016/j.ccm.2023.08.007. Epub 2023 Sep 1. Clin Chest Med. 2024. PMID: 38245366 Review.
Long-Term Safety and Efficacy Data of Golodirsen in Ambulatory Patients with Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping: A First-in-human, Multicenter, Two-Part, Open-Label, Phase 1/2 Trial.
Servais L, Mercuri E, Straub V, Guglieri M, Seferian AM, Scoto M, Leone D, Koenig E, Khan N, Dugar A, Wang X, Han B, Wang D, Muntoni F; SKIP-NMD Study Group. Servais L, et al. Among authors: seferian am. Nucleic Acid Ther. 2022 Feb;32(1):29-39. doi: 10.1089/nat.2021.0043. Epub 2021 Nov 17. Nucleic Acid Ther. 2022. PMID: 34788571 Free PMC article. Clinical Trial.
Chronic thromboembolic pulmonary hypertension.
O'Connell C, Montani D, Savale L, Sitbon O, Parent F, Seferian A, Bulifon S, Fadel E, Mercier O, Mussot S, Fabre D, Dartevelle P, Humbert M, Simonneau G, Jaïs X. O'Connell C, et al. Among authors: seferian a. Presse Med. 2015 Dec;44(12 Pt 2):e409-16. doi: 10.1016/j.lpm.2015.10.010. Epub 2015 Nov 12. Presse Med. 2015. PMID: 26585271 Review.
Safety and efficacy of gene replacement therapy for X-linked myotubular myopathy (ASPIRO): a multinational, open-label, dose-escalation trial.
Shieh PB, Kuntz NL, Dowling JJ, Müller-Felber W, Bönnemann CG, Seferian AM, Servais L, Smith BK, Muntoni F, Blaschek A, Foley AR, Saade DN, Neuhaus S, Alfano LN, Beggs AH, Buj-Bello A, Childers MK, Duong T, Graham RJ, Jain M, Coats J, MacBean V, James ES, Lee J, Mavilio F, Miller W, Varfaj F, Murtagh M, Han C, Noursalehi M, Lawlor MW, Prasad S, Rico S. Shieh PB, et al. Among authors: seferian am. Lancet Neurol. 2023 Dec;22(12):1125-1139. doi: 10.1016/S1474-4422(23)00313-7. Lancet Neurol. 2023. PMID: 37977713 Free article. Clinical Trial.
Safety, tolerability and pharmacokinetics of eteplirsen in young boys aged 6-48 months with Duchenne muscular dystrophy amenable to exon 51 skipping.
Mercuri E, Seferian AM, Servais L, Deconinck N, Stevenson H, Ni X, Zhang W, East L, Yonren S, Muntoni F; 4658-102 Study Group. Mercuri E, et al. Among authors: seferian am. Neuromuscul Disord. 2023 Jun;33(6):476-483. doi: 10.1016/j.nmd.2023.03.008. Epub 2023 Mar 24. Neuromuscul Disord. 2023. PMID: 37207382 Free article.
Functional respiratory complaints among COVID-19 survivors: a prospective cohort study.
Beurnier A, Savale L, Jaïs X, Colle R, Pham T, Morin L, Bulifon S, Noël N, Boucly A, Delbarre B, Ebstein N, Figueiredo S, Gasnier M, Harrois A, Jutant EM, Jevnikar M, Keddache S, Lecoq AL, Meyrignac O, Parent F, Pichon J, Preda M, Roche A, Seferian A, Bellin MF, Gille T, Corruble E, Sitbon O, Becquemont L, Monnet X, Humbert M, Montani D; and the Comebac Investigators; Comebac Investigators. Beurnier A, et al. Among authors: seferian a. ERJ Open Res. 2023 May 2;9(3):00063-2023. doi: 10.1183/23120541.00063-2023. eCollection 2023 Jul. ERJ Open Res. 2023. PMID: 37131523 Free PMC article.
Pulmonary complications of type 1 neurofibromatosis.
Reviron-Rabec L, Girerd B, Seferian A, Campbell K, Brosseau S, Bergot E, Humbert M, Zalcman G, Montani D. Reviron-Rabec L, et al. Among authors: seferian a. Rev Mal Respir. 2016 Jun;33(6):460-73. doi: 10.1016/j.rmr.2014.09.010. Epub 2016 Feb 8. Rev Mal Respir. 2016. PMID: 26868668 Review.
Clinical Phenotype and Outcomes of Pulmonary Hypertension Associated with Myeloproliferative Neoplasms: A Population-based Study.
Montani D, Thoré P, Mignard X, Jaïs X, Boucly A, Jevnikar M, Seferian A, Jutant EM, Cottin V, Fadel E, Simonneau G, Savale L, Sitbon O, Humbert M. Montani D, et al. Among authors: seferian a. Am J Respir Crit Care Med. 2023 Sep 1;208(5):600-612. doi: 10.1164/rccm.202210-1941OC. Am J Respir Crit Care Med. 2023. PMID: 37311222
Drug-induced pulmonary arterial hypertension: a recent outbreak.
Montani D, Seferian A, Savale L, Simonneau G, Humbert M. Montani D, et al. Among authors: seferian a. Eur Respir Rev. 2013 Sep 1;22(129):244-50. doi: 10.1183/09059180.00003313. Eur Respir Rev. 2013. PMID: 23997051 Free PMC article. Review.
84 results